Biolegend, 127626, Alexa Fluor® 488 anti-mouse Ly-6G Antibody
100microg
Catalog Number: 127626
Send an RFQ.
Pack Size6 g
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Ly-6G transfected EL-4J cell line. |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions. |
| Concentration | 0.5 mg/mL |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested IHC-F - Verified SB - Reported in the literature, not verified in house |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 10 μg/mL is recommended. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Excitation Laser | Blue Laser (488 nm) |
|---|
| Application Notes | While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416. Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662). |
|---|
| Application References(PubMed link indicates BioLegend citation) | Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC) Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC) Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC) Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC) Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC) Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC) Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete) Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete) Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete) Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed Ma C, et al. 2012. J. Leukoc. Biol. 92:1199. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed |
|---|
| Product Citations | Barkaway A, et al. 2021. Immunity. . PubMed Sweet R, et al. 2017. J Immunol. 10.4049/jimmunol.1600861. PubMed Dong X, et al. 2019. ACS Nano. 13:1272. PubMed Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed El-Naccache DW, et al. 2022. Cell Rep. 40:111150. PubMed Abdelnabi MN, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1269. PubMed Lee DE, et al. 2022. Nat Commun. 13:7613. PubMed Ullah I, et al. 2023. Cell Rep Med. 4:100893. PubMed Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed Gershater M, et al. 2022. J Immunol. 208:1595. PubMed Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed Joy MT, et al. 2019. Cell. 176:1143. PubMed Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed Jahan S, et al. 2022. J Biol Chem. :102386. PubMed Bowers E, et al. 2018. Nat Med. 24:95. PubMed Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed Craver BM, et al. 2020. Blood Adv. 4:312. PubMed Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed Leung H, et al. 2022. Nat Commun. 13:5206. PubMed Green D, et al. 2020. Oncogene. 39:5553. PubMed Wu L, et al. 2022. Theranostics. 12:842. PubMed Souza COS, et al. 2021. iScience. 24(6):102548. PubMed Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed Pach E, et al. 2021. Cancers (Basel). 13:. PubMed Du J, et al. 2021. Mol Med Rep. 23:. PubMed Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed Liu G, et al. 2022. Ann Transl Med. 10:693. PubMed Takizawa S, et al. 2022. Mol Med. 28:91. PubMed Moon H, et al. 2019. Nat Commun. 10:2225. PubMed Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed Dudeck J, et al. 2021. Immunity. 54(3):468-483.e5. PubMed Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed Boras M, et al. 2017. J Exp Med. 214:851. PubMed |
|---|
| RRID | AB_2561339 (BioLegend Cat. No. 127625) AB_2561340 (BioLegend Cat. No. 127626) |
|---|
| Structure | A 21-35 kD GPI-anchorded membrane protein |
|---|
| Distribution | Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C. |
|---|
| Cell Type | Granulocytes, Macrophages, Monocytes |
|---|
| Biology Area | Immunology, Innate Immunity |
|---|
| Antigen References | Fleming TJ, et al. 1993. J. Immunol. 151:2399. |
|---|
| Gene ID | 546644 |
|---|
| UniProt | View information about Ly-6G on UniProt.org |
|---|
| Clone | 1A8 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Lymphocyte antigen 6 complex, locus G |
|---|
| Isotype | Rat IgG2a, κ |
|---|
